Compounds > triethylenemelamine
Page last updated: 2024-11-06

triethylenemelamine and Erythremia

triethylenemelamine has been researched along with Erythremia in 4 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ELLISON, RR1
GINSBERG, V1
WATSON, J1
ROSENTHAL, N1
ROSENTHAL, RL1
Stecher, G1
Reinhardt, G1

Other Studies

4 other studies available for triethylenemelamine and Erythremia

ArticleYear
Triethylenemelamine in polycythemia vera; a therapeutic trial.
    Cancer, 1953, Volume: 6, Issue:2

    Topics: Humans; Polycythemia Vera; Triethylenemelamine

1953
Treatment of polycythemia vera with triethylene melamine; summary of thirty cases.
    A.M.A. archives of internal medicine, 1952, Volume: 90, Issue:3

    Topics: Polycythemia Vera; Triethylenemelamine

1952
Chemotherapy in polycythemia vera.
    Acta geneticae medicae et gemellologiae, 1968, Volume: 17, Issue:1

    Topics: Busulfan; Humans; Leukemia; Leukemia, Myeloid; Phosphorus Isotopes; Polycythemia Vera; Primary Myelo

1968
Pipobroman (Vercyte) - a new antineoplastic drug.
    The Medical letter on drugs and therapeutics, 1967, Apr-07, Volume: 9, Issue:7

    Topics: Anemia, Hemolytic; Antineoplastic Agents; Bone Marrow; Busulfan; Chlorambucil; Gastrointestinal Hemo

1967